White Paper

Direct-To-Patient Supply: Industry Perception And Future Trends

Source: Catalent

By Samuel Lee, Tatiana Danilova, Shuddhodana Shuddhodana, and Balint Sinko


Direct-to-patient (broadly referred to as DTP) distribution of clinical supplies can reduce or even eliminate the need for patients to travel to clinical trial sites, addressing a well-known barrier related to the successful recruitment and retention of study subjects. To better understand sponsors’ perspectives on DTP and interest in using it in their studies, 234 individuals involved in clinical supply and operations were surveyed.

The survey results cover:

  • The importance of DTP to current and future studies
  • Industry perception and understanding of DTP
  • How sponsors execute DTP studies
access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online